This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product. The contract has a ceiling value of $7,575.75 and a performance period ending on July 15, 2025. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a ceiling value of $15,151.52 and a completion date of July 29, 2025. The contract is a Firm Fixed Price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.52 and a period of performance through June 25, 2025. The contract is designated as a firm fixed-price delivery order, without any set-aside requirements. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $30,303.04 and a period of performance through July 28, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $14,645.34 and a completion date of June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a large pharmaceutical distributor, is the prime contractor for this award. The contract is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,575.75, is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance that runs through March 31, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of IMBRUVICA 280 MG TABLET 28S, a prescription medication, to the DLA. The contract has a ceiling value of $7,322.67 and an ultimate completion date of May 17, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $33,865.10 and a completion date of May 22, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product. The contract is not set aside and has a ceiling value of $15,151.52. It is a firm fixed-price contract with a completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.52 and a period of performance ending on July 15, 2025. The contract is not set aside and was awarded on June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...